Defective Integration of Activating Signals Derived from the T Cell Receptor (TCR) and Costimulatory Molecules in Both CD4+ and CD8+ T Lymphocytes of Common Variable Immunodeficiency (CVID) Patients

Overview

Journal Clin Exp Immunol

Publisher Oxford University Press

Specialty Allergy & Immunology

Date 1997 Nov 21

PMID 9367399

Citations 17

Authors

V Thon

H M Wolf

M Sasgary

J Litzman

A Samstag

I Hauber

J Lokaj

M M Eibl

Affiliations

Soon will be listed here.

Abstract

CVID is characterized by hypogammaglobulinaemia and impaired antibody production. Previous studies demonstrated defects at the T cell level. In the present study the response of purified CD4+ and CD8+ T lymphocytes to stimulation with anti-TCR monoclonal antibody (the first signal) in combination with anti-CD4 or anti-CD8, anti-CD2 and anti-CD28 MoAbs (the costimulatory signals) was investigated. Both CD4+ and CD8+ T cells from the patients showed significantly reduced IL-2 release following stimulation via TCR and costimulation via CD4 or CD8 and CD2, respectively. However, normal IL-2 production following TCR plus phorbol myristate acetate (PMA) costimulation and normal expression of an early activation marker, CD69, after TCR+CD28 stimulation indicated that TCR was able to transduce a signal. Furthermore, both IL-2 and IL-4 release were impaired in CD4+ lymphocytes following TCR+CD28 stimulation. In addition, stimulation via TCR+CD28 resulted in significantly decreased expression of CD40 ligand in the patients. These results suggest that the integration of activating signals derived from the TCR and costimulatory molecules is defective in CVID patients; the defect is not confined to costimulation via a single molecule, or restricted to cells producing Th1-type cytokines such as IL-2, and is expressed in both CD4+ and CD8+ T cell subsets.

Citing Articles

COVID-19 progression and convalescence in common variable immunodeficiency patients show dysregulated adaptive immune responses and persistent type I interferon and inflammasome activation.

Rodriguez-Ubreva J, Calafell-Segura J, Calvillo C, Keller B, Ciudad L, Handfield L Nat Commun. 2024; 15(1):10344.

PMID: 39609471 PMC: 11605083. DOI: 10.1038/s41467-024-54732-x.

Altered Transcriptome Response in PBMCs of Czech Adults Linked to Multiple PFAS Exposure: B Cell Development as a Target of PFAS Immunotoxicity.

Rudzanova B, Thon V, Vespalcova H, Martyniuk C, Piler P, Zvonar M Environ Sci Technol. 2023; 58(1):90-98.

PMID: 38112183 PMC: 10785749. DOI: 10.1021/acs.est.3c05109.

Single-cell Atlas of common variable immunodeficiency shows germinal center-associated epigenetic dysregulation in B-cell responses.

Rodriguez-Ubreva J, Arutyunyan A, Bonder M, Del Pino-Molina L, Clark S, de la Calle-Fabregat C Nat Commun. 2022; 13(1):1779.

PMID: 35365635 PMC: 8975885. DOI: 10.1038/s41467-022-29450-x.

Seeking Relevant Biomarkers in Common Variable Immunodeficiency.

Ho H, Cunningham-Rundles C Front Immunol. 2022; 13:857050.

PMID: 35359997 PMC: 8962738. DOI: 10.3389/fimmu.2022.857050.

B cells promote CD8 T cell primary and memory responses to subunit vaccines.

Klarquist J, Cross E, Thompson S, Willett B, Aldridge D, Caffrey-Carr A Cell Rep. 2021; 36(8):109591.

PMID: 34433030 PMC: 8456706. DOI: 10.1016/j.celrep.2021.109591.

References

Stagg A, Funauchi M, Knight S, Webster A, Farrant J . Failure in antigen responses by T cells from patients with common variable immunodeficiency (CVID). Clin Exp Immunol. 1994; 96(1):48-53. PMC: 1534526. DOI: 10.1111/j.1365-2249.1994.tb06228.x. View

Fischer M, Hauber I, Vogel E, Wolf H, Mannhalter J, Eibl M . Defective interleukin-2 and interferon-gamma gene expression in response to antigen in a subgroup of patients with common variable immunodeficiency. J Allergy Clin Immunol. 1993; 92(2):340-52. DOI: 10.1016/0091-6749(93)90178-i. View

Izquierdo Pastor M, Reif K, Cantrell D . The regulation and function of p21ras during T-cell activation and growth. Immunol Today. 1995; 16(3):159-64. DOI: 10.1016/0167-5699(95)80134-0. View

Noelle R . The role of gp39 (CD40L) in immunity. Clin Immunol Immunopathol. 1995; 76(3 Pt 2):S203-7. DOI: 10.1016/s0090-1229(95)90234-1. View

Spickett G, Farrant J, North M, Zhang J, Morgan L, Webster A . Common variable immunodeficiency: how many diseases?. Immunol Today. 1997; 18(7):325-8. DOI: 10.1016/s0167-5699(97)01086-4. View

Durie F, Foy T, Masters S, Laman J, Noelle R . The role of CD40 in the regulation of humoral and cell-mediated immunity. Immunol Today. 1994; 15(9):406-11. DOI: 10.1016/0167-5699(94)90269-0. View

Testi R, DAmbrosio D, De Maria R, Santoni A . The CD69 receptor: a multipurpose cell-surface trigger for hematopoietic cells. Immunol Today. 1994; 15(10):479-83. DOI: 10.1016/0167-5699(94)90193-7. View

Fuleihan R, Ramesh N, Horner A, Ahern D, Belshaw P, Alberg D . Cyclosporin A inhibits CD40 ligand expression in T lymphocytes. J Clin Invest. 1994; 93(3):1315-20. PMC: 294093. DOI: 10.1172/JCI117089. View

Tsuji T, Nibu R, Iwai K, Kanegane H, Yachie A, Seki H . Efficient induction of immunoglobulin production in neonatal naive B cells by memory CD4+ T cell subset expressing homing receptor L-selectin. J Immunol. 1994; 152(9):4417-24. View

10.

Bierer B, Burakoff S . T cell receptors: adhesion and signaling. Adv Cancer Res. 1991; 56:49-76. DOI: 10.1016/s0065-230x(08)60477-7. View

11.

Broom B, de la Concha E, Webster A, Janossy G, Asherson G . Intracellular immunoglobulin production in vitro by lymphocytes from patients with hypogammaglobulinaemia and their effect on normal lymphocytes. Clin Exp Immunol. 1976; 23(1):73-7. PMC: 1538368. View

12.

Chomczynski P . A reagent for the single-step simultaneous isolation of RNA, DNA and proteins from cell and tissue samples. Biotechniques. 1993; 15(3):532-4, 536-7. View

13.

Fuleihan R, Ahern D, Geha R . Expression of the CD40 ligand in T lymphocytes and induction of IgE isotype switching. Int Arch Allergy Immunol. 1995; 107(1-3):43-4. DOI: 10.1159/000236925. View

14.

Gordon J . CD40 and its ligand: central players in B lymphocyte survival, growth, and differentiation. Blood Rev. 1995; 9(1):53-6. DOI: 10.1016/0268-960x(95)90040-3. View

15.

Hollenbaugh D, Grosmaire L, Kullas C, Chalupny N, Noelle R, Stamenkovic I . The human T cell antigen gp39, a member of the TNF gene family, is a ligand for the CD40 receptor: expression of a soluble form of gp39 with B cell co-stimulatory activity. EMBO J. 1992; 11(12):4313-21. PMC: 557004. DOI: 10.1002/j.1460-2075.1992.tb05530.x. View

16.

Noelle R, Ledbetter J, Aruffo A . CD40 and its ligand, an essential ligand-receptor pair for thymus-dependent B-cell activation. Immunol Today. 1992; 13(11):431-3. DOI: 10.1016/0167-5699(92)90068-I. View

17.

Foley K, Leonard M, Engel J . Quantitation of RNA using the polymerase chain reaction. Trends Genet. 1993; 9(11):380-5. DOI: 10.1016/0168-9525(93)90137-7. View

18.

Farrington M, Grosmaire L, Nonoyama S, Fischer S, Hollenbaugh D, Ledbetter J . CD40 ligand expression is defective in a subset of patients with common variable immunodeficiency. Proc Natl Acad Sci U S A. 1994; 91(3):1099-103. PMC: 521461. DOI: 10.1073/pnas.91.3.1099. View

19.

Keightley R, Cooper M, Lawton A . The T cell dependence of B cell differentiation induced by pokeweed mitogen. J Immunol. 1976; 117(5 Pt 1):1538-44. View

20.

Conlon K, Ochoa A, Kopp W, Ortaldo J, Urba W, Longo D . Enhanced lymphokine production and lymphokine receptor expression in multiple antibody-stimulated human CD4+ peripheral blood lymphocytes. J Immunol. 1992; 149(10):3278-89. View